Sign in
GOVX Stock Price, Chart, Stats & News
GeoVax Labs, Inc.
Save
1.26M
Market cap
–
Current P/E
9.65x
Forward P/E
GOVX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 98.35% |
Operating margin | -761.63% |
Pretax margin | -754.69% |
Net margin | -754.69% |
Effective tax rate | – |
ROA | -375.99% |
ROE | -489.66% |
D/E | – |
Interest coverage ratio | – |
GOVX valuation
P/E | – |
P/S | 0.42x |
P/B | 0.23x |
P/CF | -0.05x |
P/FCF | -0.06x |
P/OCF | -0.05x |
PEG | -0.00x |
EV multiple | -0.25x |
About
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa.
Similar securities
Based on sector and market capitalization
Report issue